Eveliqure Biotechnologies is a startup based in Austria.
Eveliqure Biotechnologies is a startup based in Austria.
Eveliqure Biotechnologies is an Austrian biotech developing live attenuated, orally delivered vaccines to prevent diarrhoeal diseases. Its lead candidate, ShigETEC, is designed to protect against Shigella and enterotoxigenic E. coli (ETEC) and is in Phase 2b clinical testing.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.